DURECT Corporation
General ticker "DRRX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $30.5M (TTM average)
DURECT Corporation follows the US Stock Market performance with the rate: 19.9%.
Estimated limits based on current volatility of 0.9%: low 1.90$, high 1.94$
Factors to consider:
- US accounted for 54.0% of revenue in the fiscal year ended 2023-12-31
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.58$, 1.53$]
- 2025-12-31 to 2026-12-31 estimated range: [0.58$, 1.48$]
Short-term DRRX quotes
Long-term DRRX plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $2.03MM |
| Operating Expenses | $20.94MM |
| Operating Income | $-18.91MM |
| Non-Operating Income | $0.50MM |
| R&D Expense | $10.38MM |
| Income(Loss) | $-18.41MM |
| Profit(Loss)* | $-8.32MM |
| Stockholders Equity | $9.13MM |
| Inventory | $0.11MM |
| Assets | $18.35MM |
| Operating Cash Flow | $-19.09MM |
| Investing Cash Flow | $18.04MM |
| Financing Cash Flow | $-16.35MM |
| Earnings Per Share** | $-0.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.